-to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-α-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110 [1]

Diabetologia

Volumn 46, Issue 7, 2003, Pages 1020-1021

  Rotondi, M ^a   Romagnani, P ^a   Brozzetti, A ^a   Santeusanio, F ^a   Serio, M ^a   Falorni, A ^a  

^a Department of Internal Medicine ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHEMOKINE;

AUTOIMMUNITY; BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; PRIORITY JOURNAL; SERUM;

AUTOANTIBODIES; CHEMOKINES, CXC; DIABETES MELLITUS, TYPE 1; HUMANS; INTERFERON TYPE II;

EID: 0042572469     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1134-4     Document Type: Letter

References (7)

1. Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-g-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110
2. Shimada A, Morimoto J, Kodama K et al. (2001) Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 24:510-515
3. Rotondi M, Lazzeri E, Romagnani P, Serio M (2003) Role for interferon-γ inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest 26:177-180
4. Picchio ML, Falorni A, De Giorgi G et al. (1997) Incidence of IDDM in the 0-29 yrs age-group in Umbria, Italy. Diabetes Nutr Metab 10:120-125
5. Lorini R, d'Annunzio G, Vitali L, Scaramuzza A (1996) IDDM and autoimmune thyroid disease in the paediatric age group. J Pediatr Endocrinol Metab 9 [Suppl 1]:89-94
6. Gambelunghe G, Forini F, Laureti S et al. (2000) Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol 52:565-573
7. Romagnani P, Rotondi M, Lazzeri E et al. (2002) Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol 161:195-206